Opko Health, Inc.

Pharmaceutical company · Miami, Florida, United States · Nasdaq: OPK

Opko Health, Inc. is a pharmaceutical company headquartered in Miami, Florida, United States. Its shares trade on Nasdaq under the ticker OPK. The US FDA lists 1 medical device site registered to the company. It has reported private securities offerings to the US SEC, most recently $175 million sold in a notice filed in 2013.

Profile compiled from public records. Is this your company? Request a correction or update

Opko Health at a glance

Typepharmaceutical company
HeadquartersMiami, Florida, United States
Stock listingNasdaq: OPK
SEC industryPharmaceutical Preparations
FDA-registered sites1
SEC CIK944809

What does Opko Health do?

Device types listed with the FDA

Multi-analyte test system with algorithmic analysis for detection of prostate cancer

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $175 million sold (2013).

Where is Opko Health located?

Headquarters: Miami, Florida, United States

  • Elmwood Park, New JerseyBioReference Health, LLC · FDA device site

Frequently asked questions about Opko Health

Where is Opko Health headquartered?

Opko Health, Inc. is headquartered in Miami, Florida, United States.

What does Opko Health do?

Opko Health, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Opko Health a public company?

Yes. Opko Health, Inc. trades on Nasdaq under the ticker OPK.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.